India Bioeconomy Report 2025
Union Minister of Government of India has released the “India Bioeconomy Report 2025” (IBER 2025) at the BIRAC Foundation Day ceremony at the National Media Centre
During the meeting the following informations were shared on India’s Bio Economy Growth :
India’s bioeconomy has grown from $10 billion in 2014 to $165.7 billion in 2024, marking a 16-fold increase. This growth is attributed to the government’s commitment to fostering biotechnology as a key economic pillar.
The bioeconomy now contributes 4.25% to India’s GDP, comparable to major economies like the US and China
The number of biotech startups has surged from 50 to over 10,075, showcasing a thriving ecosystem.
Government has recently approved BIO-E3 Policy i.e Biotechnology for Economy, Employment, and Environment—which aims to accelerate research, innovation, and entrepreneurship in the sector. Assam is the first state to adopt this framework. Under this policy, initiatives such as Bio-AI Hubs, Bio foundries, and bio-enabler hubs will be set up to integrate advanced technologies with biomanufacturing.
Government has initiated BioSaarthi, a pioneering global mentorship initiative aimed at nurturing biotech startups. Designed as a six-month cohort, BioSaarthi will facilitate structured mentor-mentee engagements, offering personalized guidance to emerging entrepreneurs in the biotech sector. This initiative will strengthen India’s biotech ecosystem by fostering innovation, enhancing industry-academia collaboration, and positioning Indian startups for global success. The initiative would engage overseas experts, particularly from Indian diaspora as international mentors who would volunteer to give back to the society
The Key highlights of the India BioEconomy Report (IBER) 2025 :
Sector Growth
- India’s bioeconomy grew by 9.8% in 2024, reaching $165.7 billion, contributing 4.25% to the national GDP, aligning with global leaders like the US (5%) and China (4%)
- The sector is on track to achieve $300 billion by 2030 and $1 trillion by 2047, with required compound annual growth rates (CAGR) of 10.6% (2024–2030) and 7.5% (2030–2047)
Segment Contributions
- BioIndustrial led with a 47.2% share, followed by BioPharma at 35.2%
- Maharashtra emerged as the top contributing state, followed by Karnataka and Telangana
Startup Ecosystem
- India now has over 10,075 biotech startups, supported by initiatives like Bio-Nests, which provide incubation facilities
- Plans include expanding incubation spaces to 2 million square feet and establishing a $3 billion Biotech Venture Fund by 2028
Policy Recommendations
The report outlines strategies across five key sectors: BioPharma, BioAgri, BioIndustrial, TechMed, and startups:
- Launching a National Bio-fortification Mission.
- Establishing biomanufacturing consortia and incentivizing academic-industry collaborations.
- Strengthening the Ayushman Bharat Digital Mission to enhance healthcare delivery
Strategic Roadmap
The “5-5-5 Model” emphasizes:
- Five key sectors for focus.
- Five implementation phases (e.g., acceleration phase in 2025–2026).
- Five core enablers: policy reforms, skilled workforce, shared infrastructure, partnerships, and global promotion
Frontier Technologies
Five transformative technologies identified for disproportionate growth include:
- Cell & Gene Therapy.
- Synthetic Biology.
- AI + Biology integration.
- Precision Agriculture.
- Biomanufacturing
Regional Clusters
Specialized regional clusters are being developed:
- Bengaluru-Mysore-Mangalore for BioPharma and Digital Health.
- Hyderabad for vaccines and biosimilars.
- Pune-Mumbai for industrial biotechnology
The IBER 2025 underscores India’s potential to become a global leader in biotechnology through coordinated efforts in policy-making, infrastructure development, and innovation promotion.
Source: https://pib.gov.in/PressReleasePage.aspx?PRID=2113745
